Impax Laboratories Inc (NASDAQ:IPXL)

19.70
Delayed Data
As of Apr 23
 -0.20 / -1.01%
Today’s Change
12.80
Today|||52-Week Range
25.70
+18.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues596.0M860.5M824.4M775.8M
 
 
 
 
 
Cost of Goods Sold246.5M439.4M371.5M407.7M
 
 
 
 
 
Depreciation And Amortization34.0M68.6M88.3M106.7M
 
 
 
 
 
 
Operating ExpensesGross Income315.6M352.4M364.6M261.4M
 
 
 
 
 
General Expenses218.5M265.0M319.5M281.4M
 
 
 
 
 
Research And Development79.1M77.0M80.5M77.4M
 
 
 
 
 
Total Operating Expenses499.0M773.0M779.3M795.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income97.0M87.4M45.1M-20.1M
 
 
 
 
 
Extraordinary Credit0.00--0.0031.0M
 
 
Extraordinary Charge-8.2M-47.8M-580.6M-418.9M
 
 
 
 
 
Interest Expense On Debt0.0027.3M41.4M54.4M
 
 
 
 
Other Expenses270.0K45.9M-464.0K10.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income90.6M59.4M-576.3M-451.0M
 
 
 
 
 
Income Taxes-33.2M-20.4M-104.3M-18.3M
 
 
 
 
 
Net Income57.4M39.0M-472.0M-469.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.2M69.6M71.1M71.9M
 
 
 
 
 
Shares To Calculate EPS Diluted70.5M72.0M71.1M71.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.81$0.54-$6.63-$6.53
 
 
 
 
 
EPS Diluted$0.81$0.54-$6.63-$6.53